Home›Insulin Glargine Aglr›Insulin Glargine Aglr + Acetazolamide

Does Insulin Glargine Aglr Interact with Acetazolamide?

Insulin Glargine Aglr and Acetazolamide have a unknown drug interaction according to U.S. FDA drug labeling data. Table 8: Clinically Significant Drug Interactions with REZVOGLAR Drugs that May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), sulfonamide antibiotics. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Insulin Glargine Aglr Class
Insulin Analog
Acetazolamide Class
Carbonic Anhydrase Inhibitor
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Insulin Glargine Aglr and your doctor is considering prescribing Acetazolamide (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Insulin Glargine Aglr(Rezvoglar Kwikpen)+💊 Acetazolamide

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Insulin Analog
Drug B class
Carbonic Anhydrase Inhibitor
Source
FDA drug label - insulin glargine-aglr

What this means in plain English

Table 8: Clinically Significant Drug Interactions with REZVOGLAR Drugs that May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), sulfonamide antibiotics.

About Insulin Glargine Aglr and Acetazolamide

Insulin Glargine Aglr is an Insulin Analog, while Acetazolamide is a Carbonic Anhydrase Inhibitor. Insulin Glargine Aglr is also sold under the brand name Rezvoglar Kwikpen. Insulin Glargine Aglr is given by injection under the skin, whereas Acetazolamide is given by intravenous (IV) infusion.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Insulin Glargine Aglr and Acetazolamide against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.